Hudson Bay Capital Management LP - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$894,600
-78.6%
60,000
-87.5%
0.00%
-77.8%
Q1 2023$4,187,100
-4.3%
480,172
-31.2%
0.02%
-60.0%
Q4 2022$4,373,325
-5.7%
697,500
-47.4%
0.04%
+9.8%
Q3 2022$4,638,000
+4.8%
1,325,000
-11.7%
0.04%
+24.2%
Q2 2022$4,425,000
+81.3%
1,499,900
+91.1%
0.03%0.0%
Q1 2022$2,441,000
+11.1%
785,000
+20.8%
0.03%
+50.0%
Q4 2021$2,197,000
+58.4%
650,000
+71.0%
0.02%
+15.8%
Q3 2021$1,387,000
+6.0%
380,052
+26.7%
0.02%
+18.8%
Q2 2021$1,308,000
+40.5%
300,000
+46.3%
0.02%
+45.5%
Q1 2021$931,000
-12.5%
205,000
+10.5%
0.01%
+83.3%
Q4 2020$1,064,000
-9.0%
185,518
-44.6%
0.01%
-70.0%
Q2 2020$1,169,000
+267.6%
335,000
+55.8%
0.02%
+150.0%
Q1 2020$318,000
-50.1%
215,000
-33.8%
0.01%
-42.9%
Q4 2019$637,000
+537.0%
325,000
+2221.4%
0.01%
+600.0%
Q2 2019$100,00014,0000.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 2,023,369$27,154,0009.26%
Omega Fund Management, LLC 551,477$7,401,0005.46%
Foresite Capital Management III, LLC 1,562,040$20,963,0004.51%
Versant Venture Management, LLC 1,048,601$14,072,225,0004.39%
Boxer Capital, LLC 2,094,000$28,101,0003.18%
Opaleye Management Inc. 697,500$9,360,0002.42%
Abingworth LLP 273,417$3,667,0002.10%
DAFNA Capital Management LLC 294,511$3,952,0001.85%
NEXTHERA CAPITAL LP 828,655$11,121,0001.72%
Vivo Capital, LLC 906,000$12,158,0001.57%
View complete list of CYMABAY THERAPEUTICS INC shareholders